Regency Lifesciences (India) Private Limited, a active private limited company, was established on 23 December 2009 in Bangalore, Karnataka, India. Engaging in medical equipment retail & distribution within the professional, scientific and technical sector, it holds CIN: U24231KA2009PTC051931. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Jeslet Abel (Director), Abel Boodala Alexander (Managing Director). Past directors included Jeslet Abel, Balu Reddy Durgaprasad. It holds ₹3.16 Cr open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.118/5, Hennur Main Road Kacharakanahalli, St Thomas Town Post, Bangalore, Karnataka, 560084.
U24231KA2009PTC051931
051931
23 December 2009
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Regency Lifesciences (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jeslet Abel | Director | 28 Jun 2019 | Current |
| Abel Boodala Alexander | Managing Director | 23 Dec 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jan 2015 | Past |
| Pramod Abcsdd | Director | 22 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Regency Lifesciences (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.24% increase. The company also saw a substantial improvement in profitability, with a 25.63% increase in profit. The company's net worth Soared by an impressive increase of 32.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Regency Lifesciences (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹31,550,000.00
₹5,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2025 | Others | ₹1.55 M | Open |
| 19 Mar 2025 | Canara Bank | ₹3.00 Cr | Open |
| 04 Oct 2022 | Indian Overseas Bank | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Regency Lifesciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Regency Lifesciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regency Lifesciences (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 1.55 M with Charge ID 101103923 was registered on 20 May 2025. was completed.
Progress on A charge with Canara Bank amounted to Rs. 30.00 M with Charge ID 101062839 was registered on 19 Mar 2025. was documented.
A charge registered on 04 Oct 2022 via Charge ID 100622623 with Indian Overseas Bank was fully satisfied on 14 Oct 2024. was recorded as a recent event.
Regency Lifesciences (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Regency Lifesciences (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Progress on A charge with Indian Overseas Bank amounted to Rs. 5.50 M with Charge ID 100622623 was registered on 04 Oct 2022. was documented.
The CIN of Regency Lifesciences (India) Private Limited is U24231KA2009PTC051931.
Regency Lifesciences (India) Private Limited is headquartered at No.118/5, Hennur Main Road Kacharakanahalli, St Thomas Town Post, Bangalore, Karnataka, 560084.
Regency Lifesciences (India) Private Limited was incorporated on 23 December 2009.
The current directors of Regency Lifesciences (India) Private Limited are
The primary industry of Regency Lifesciences (India) Private Limited is Professional, Scientific And Technical.
Regency Lifesciences (India) Private Limited is unlisted.
The authorized capital of Regency Lifesciences (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Regency Lifesciences (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX